Chronic lymphocytic leukaemia still an incurable disease

Drugs and Therapy Perspectives

Volumn 16, Issue 10, 2000, Pages 4-9

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CLADRIBINE; CYCLOPHOSPHAMIDE; FLUDARABINE; PENTOSTATIN; PREDNISONE; VINCRISTINE;

ALGORITHM; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FATALITY; HUMAN; REVIEW; TREATMENT PLANNING;

EID: 0034613693     PISSN: 11720360     EISSN: None     Source Type: Journal    
DOI: 10.2165/00042310-200016100-00002     Document Type: Review

References (13)

1. Management of chronic lymphocytic leukaemia
2. Chronic leukaemias
3. Chronic lymphocytic leukaemia: Staging and prognostic factors
4. Richter's syndrome: A report on 39 patients
5. A randomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia: A CALGB, SWOG, CTC/NCI-C and ECOG inter-group study
6. Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment
7. A 3-day schedule of fludarabine in previously treated chronic leukemia
8. Tumor lysis syndrome: An uncommon complication of fludarabine therapy of chronic lymphocyctic leukemia
9. Second malignancies as a consequence of nucleoside analog therapy of chronic lymphoid leukemias
10. A randomized trial comparing chlorambucil plus prednisone vs cyclophosphamide, melphalan, and prednisone in the treatment of chronic lymphocyctic leukemia stages B and C
11. Long-term follow-up of patients with chronic lymphocyctic leukemia (CLL) receiving fludarabine regimens as initial therapy